Respiratory Disorders: Obstructive Airway Diseases and Pulmonary Vascular Conditions

Study Material: Alterations in Respiration - Obstructive Airway & Pulmonary Vascular Disorders

Source Information: This study material has been compiled from a copy-pasted text and a lecture audio transcript.

📚 Introduction to Respiratory Alterations

This study guide explores significant alterations in respiratory function, focusing on two main categories: Obstructive Airway Disorders and Pulmonary Vascular Disorders. Understanding these conditions is crucial for comprehending how various factors can impede airflow, gas exchange, and blood flow within the lungs, leading to compromised respiratory health.

🌬️ Obstructive Airway Disorders

Obstructive airway disorders are characterized by a primary limitation in expiratory airflow. This means air has difficulty leaving the lungs, often due to narrowing or blockage of the airways.

1. Bronchial Asthma

Bronchial asthma is a chronic inflammatory disease of the airways. It is defined by:

Reversible Airway Obstruction: The obstruction can be reversed, either spontaneously or with treatment, though not always completely in all patients.
Airway Inflammation: Persistent inflammation of the bronchial lining.
Airway Hyper-responsiveness: An exaggerated response to various stimuli, leading to bronchoconstriction.

📚 Key Concept: Asthma results from complex interactions among inflammatory cells, mediators, and resident cells and tissues in the airway.

Causes and Triggers of Asthma:

Allergens: Common triggers, especially in individuals with a family history of atopic allergy (often childhood/adolescent onset).
Respiratory Tract Infections: Viral or bacterial infections can exacerbate asthma.
Hyperventilation, Cold Air, Exercise: Physical stimuli that can induce bronchospasm.
Drugs and Chemicals: Certain medications (e.g., NSAIDs, beta-blockers) or occupational irritants.
Emotional Upsets: Stress and anxiety can trigger attacks.

Pathophysiology of an Asthmatic Attack:

Type I Hypersensitivity: Asthmatic airways are highly sensitive. Excessive IgE antibodies coat the mucous membranes and bind to smooth muscle around the bronchioles.
Allergen Binding: When IgE encounters an allergen, it forms complexes, triggering mast cells to release histamine.
Bronchospasm: Histamine stimulates smooth muscle contraction, causing bronchospasm and narrowing the airway lumen.
Inflammation & Mucus: The lumen further narrows due to swelling (edema) of mucous membranes and excessive mucus production, which can form plugs.
Clinical Manifestations: This leads to dyspnea (difficult breathing) and wheezing. Air movement becomes very difficult.

⚠️ Status Asthmaticus: A severe, prolonged asthmatic attack that does not respond to usual therapy. It involves severe bronchospasm, bronchial mucosa edema, and mucus plugging, leading to progressive airway obstruction and prolonged expiration.

Diagnostic Indicators during an Attack:

FEV1.0 (Forced Expiratory Volume in 1 second): Decreased.
PEFR (Peak Expiratory Flow Rate): Decreased.
A fall in FEV1.0 or PEFR below 25% of the predicted value suggests impending respiratory failure.

2. Chronic Obstructive Pulmonary Disease (COPD)

COPD is a group of respiratory disorders characterized by chronic and recurrent obstruction of airflow in the pulmonary airways.

📚 Key Characteristics:

Preventable: Largely preventable, with smoking being the most common cause.
Late Symptom Onset: Clinical findings are often absent in early stages; symptoms appear when the disease is advanced.
Risk Factors:
- Smoking: Primary cause.
- Inhaled Toxins: Occupational exposure.
- Alpha1-Antitrypsin Deficiency: An inherited genetic predisposition.

a. Emphysema (Type A COPD - "Pink Puffers")

Emphysema is characterized by:

Loss of Lung Elasticity: Reduced ability of the lungs to recoil.
Abnormal, Permanent Enlargement of Air Spaces: Distal to the terminal bronchioles.
Destruction of Alveolar Walls and Capillary Beds: Without obvious fibrosis.

Pathophysiology:

Protease-Antiprotease Imbalance: Emphysema results from the breakdown of elastin and other alveolar wall components by enzymes called proteases (e.g., elastase).
Sources of Proteases: These enzymes are released from inflammatory cells like polymorphonuclear leukocytes and alveolar macrophages.
Protective Mechanism: Normally, the lung is protected by alpha1-antitrypsin, an antiprotease enzyme.
Causes of Imbalance:
- Smoking: Stimulates inflammatory cells, enhances elastase release, increases elastase activity, and activates mast cells. It also reduces body stores of alpha1-antitrypsin.
- Alpha1-Antitrypsin Deficiency: An inherited autosomal recessive disorder (PI genes) leading to low levels of this protective enzyme. Accounts for ~1% of COPD cases, especially in younger individuals (<40 years old) with emphysema.

b. Chronic Bronchitis (Type B COPD - "Blue Bloaters")

In chronic bronchitis, airway obstruction is caused by inflammation of the major and small airways.

📚 Diagnostic Criteria: A history of a chronic productive cough persisting for at least 3 months for at least 2 consecutive years, in the absence of other diseases.

Pathophysiology:

Inflammation: Leads to edema and hyperplasia (enlargement) of submucosal glands.
Excess Mucus Excretion: Increased mucus production into the bronchial tree, contributing to obstruction.
Commonly Affected: Middle-aged men.
Causes: Primarily associated with chronic irritation from smoking and recurrent infections. Infections are often a result, not a cause, of the underlying problem.

📊 Comparison of Emphysema and Chronic Bronchitis

🫀 Pulmonary Vascular Disorders

These disorders affect the blood vessels within the lungs, impacting the crucial process of ventilation-perfusion matching (gas exchange and blood flow).

1. Pulmonary Embolism (PE)

A pulmonary embolism develops when a bloodborne substance lodges in a branch of the pulmonary artery, obstructing blood flow.

📚 Types of Emboli:

Thrombus: Most common, usually from deep vein thrombosis (DVT) in the lower extremities.
Air: Accidentally injected during IV infusion.
Fat: Mobilized from bone marrow after a fracture or traumatized fat depot.
Amniotic Fluid: Enters maternal circulation after membrane rupture during delivery.

Risk Factors for Venous Thrombosis (and thus PE):

Virchow's Triad Components:
- Venous Stasis: Slow blood flow.
- Venous Endothelial Injury: Damage to vessel lining.
- Hypercoagulability States: Increased tendency for blood clotting.
Clinical Risk Factors: Bed rest, trauma, surgery, childbirth, obesity, hip/femur fractures, advanced age, myocardial infarction, congestive heart failure.

Effects of Emboli on Pulmonary Circulation:

Mechanical Obstruction: Direct blockage of blood flow.
Neurohumoral Reflexes: Cause vasoconstriction in the affected area.
Consequences: Reflex bronchoconstriction, wasted ventilation, impaired gas exchange, loss of alveolar surfactant.
Severe Cases: Massive emboli can lead to pulmonary hypertension and right heart failure.

Clinical Manifestations:

Most Frequent: Chest pain, dyspnea, increased respiratory rate.
Massive Emboli (often fatal): Sudden collapse, crushing substernal chest pain, shock, loss of consciousness, rapid/weak pulse, low blood pressure, distended neck veins, cyanotic skin.

2. Pulmonary Hypertension

Pulmonary hypertension describes the elevation of pressure in the pulmonary arterial system. The pulmonary circulation is normally a low-pressure system (mean pressure ~15 mmHg).

Causes of Elevated Pulmonary Artery Pressure:

Elevation in Left Atrial Pressure:
- Mitral valve stenosis
- Left ventricular heart failure
Increased Pulmonary Blood Flow:
- Left-to-right shunts in congenital heart diseases (e.g., atrial/ventricular septal defects, patent ductus arteriosus).
Increased Pulmonary Vascular Resistance:
- Hypoxia: A common cause. Unlike systemic vessels, pulmonary vessels constrict in response to low oxygen. This is why it's common in advanced chronic bronchitis and emphysema.
- Excessive Obliteration/Obstruction of Pulmonary Vessels:
  - Vasculitis
  - Connective tissue diseases
  - Fibrotic processes in interstitial lung diseases

3. Cor Pulmonale

📚 Definition: Cor pulmonale refers to right heart failure resulting from primary lung disease and longstanding pulmonary hypertension. It involves hypertrophy (enlargement) and eventual failure of the right ventricle.

Clinical Manifestations:

Signs and symptoms of the primary lung disease (e.g., shortness of breath, productive cough, worsening during heart failure).
Signs of right-sided heart failure:
- Venous distention (e.g., jugular venous distention)
- Peripheral edema
- Plethora (redness) and cyanosis (due to compensatory polycythemia and arterial desaturation).
- Warm, moist skin.
- Drowsiness and altered consciousness (due to carbon dioxide retention).

💡 Management: Focuses on treating the underlying lung disease and the heart failure. Low-flow oxygen therapy may be used to reduce pulmonary hypertension and polycythemia associated with severe hypoxemia.